Subscribe

RSSAdd blog to your RSS reader
RSSGet blog updates by email

Popular Topics

All Topics

Recent Posts

Archives

Complete Archives

Contact Us

212.451.2258

ADVERTISING@OLSHANLAW.COM

Advertising Law Blog

The Advertising Law Blog provides commentary and news on developing legal issues in advertising, promotional marketing, Internet, and privacy law. This blog is sponsored by the Advertising, Marketing & Promotions group at Olshan. The practice is geared to servicing the needs of the advertising, promotional marketing, and digital industries with a commitment to providing personal, efficient and effective legal service.

Showing 11 posts in COVID-19.

Webinar - Retail Marketing Compliance in Post-COVID Era

Posted on September 23, 2020 by Tamara Carmichael, Claudia B. Dubón, Mary L. Grieco, Steven R. Gursky, Andrew B. Lustigman, Scott Shaffer, Morgan E. Spina

Our fast-moving webinar discussed key issues involving marketing and business practices in the current environment. Read More ›

Tags: compliance, COVID-19, retail, webinar  |  Comments

Sweepstakes and Promotions During a Pandemic

Posted on September 15, 2020 by Andrew B. Lustigman, Morgan E. Spina

In the context of the coronavirus pandemic, many companies have turned to online sweepstakes and promotions as a means of both promoting their brand and showing support to coronavirus relief efforts. Certainly, sweepstakes and promotions can be an effective way to achieve these dual purposes.   As we previously reported, brands that have hastily run promotions without thinking through the consequences of various events have run into a firestorm of negative publicity as well as potential class actions.  Making sure that the promotion incorporates the items below can help ensure that a promotion is legal, properly structured, and contains appropriate protections for the brand. Read More ›

Tags: COVID-19, Force Majeure, FTC, pandemic, Sweepstakes Law, Sweeptstakes Contest  |  Comments

FTC Files Complaints against Companies That Failed to Fulfill Promises of Fast Delivery of Protective Equipment

Posted on September 15, 2020 by Andrew B. Lustigman, Morgan E. Spina

The importance of timely delivery remains a top priority, particularly when making enhanced delivery promises. In light of the impact of the COVID-19 pandemic, the FTC has filed complaints against three online merchandisers it believes have failed to deliver on quick shipping promises in contravention of the FTC’s Mail, Internet and Telephone Order Rule, commonly known as the Mail Order Sales Rule. Read More ›

Tags: COVID-19, FTC  |  Comments

Federal Enforcement against Marketers Making Allegedly Deceptive Coronavirus-Related Health Claims

Posted on September 15, 2020 by Andrew B. Lustigman, Morgan E. Spina

As we have previously reported, like other regulators, the FTC has been quick to take action against companies that it believes are seeking to take advantage of the coronavirus pandemic. The FTC has sent warning letters to approximately 300 companies that it has alleged were making unsubstantiated or potentially misleading claims about products related to the coronavirus. Recently, the FTC has taken decisive action against a company to which it has previously sent a warning letter, alleging that such company has continued to make deceptive and misleading advertising claims in spite of the FTC’s warning. Read More ›

Tags: COVID-19, FTC  |  Comments

Andrew Lustigman Contributes to Business Ethics During COVID-19 Companies Digest Article

Posted on September 10, 2020 by Andrew B. Lustigman

Andrew Lustigman, head of Olshan’s Advertising, Marketing & Promotions Practice Group, was featured in a Companies Digest article comprising assessments by leading business law attorneys. Read More ›

Tags: COVID-19, FDA, FTC, SEC  |  Comments

Andrew Lustigman Quoted in AdAge on the Advertisement Agreements Between TikTok and Brands

Posted on August 7, 2020 by Andrew B. Lustigman

Andrew Lustigman, head of Olshan’s Advertising, Marketing & Promotions Practice Group, was quoted in AdAge (subscription required) regarding the impending ban that may happen to TikTok and how it would affect the brands that use the platform to publish its advertisements. Read More ›

Tags: Advertising, Contract, COVID-19, Force Majeure, Social Media, Social Media Marketing  |  Comments

SEC Brings Enforcement Actions Against Companies for Misleading COVID-19 Claims

Posted on May 28, 2020 by Kenneth M. Silverman, Morgan E. Spina, Robert C. Gagne

The U.S. Securities and Exchange Commission (the “SEC”) filed enforcement actions on May 14, 2020, against two unrelated companies, Turbo Global Partners, Inc. (“Turbo”) and Applied BioSciences Corp. (“APPB”). The SEC charged both companies with securities fraud based on alleged materially misleading statements that the companies were offering and shipping products to combat the coronavirus (COVID-19). These actions taken by the SEC are consistent with approaches taken by other regulators, including the Federal Trade Commission and Food and Drug Administration (the “FDA”), with regard to misleading statements made in connection with coronavirus-related products. On the whole, regulators appear to be particularly cognizant of businesses and individuals seeking to take improper advantage of the circumstances created by the global pandemic, and as such are taking action against such companies and individuals. Read More ›

Tags: COVID-19, FDA, FTC, SEC  |  Comments

Andrew Lustigman Quoted in Bloomberg Law on DOJ’s, FTC’s and FDA’s Attack on Coronavirus Fraudsters

Posted on May 20, 2020 by Andrew B. Lustigman

Andrew Lustigman, head of Olshan’s Advertising, Marketing & Promotions Practice Group, was quoted in a Bloomberg Law article on the coordinated attack on coronavirus scams led by The Justice Department (“DOJ”), the Federal Trade Commission (“FTC”), and the Food and Drug Administration (“FDA”). All three agencies have filed charges against and have sent warning letters to people and companies for advertising unapproved COVID-19 treatments or preventatives. Given the import that these efforts have to public health during the pandemic, the agencies’ attention is intensely focused on preventing coronavirus fraud, so while the DOJ is investigating a wide range of fraudulent activity, the FTC and the FDA are evaluating false claims about treatments and cures. “That intensity is shown by how quickly the agencies are taking cases to court and asking for orders to stop the fraudsters,” said Mr. Lustigman. Wasting no time, the DOJ has filed at least four civil lawsuits against people allegedly selling fraudulent cures/treatments, obtaining temporary restraining orders against three of the defendants. The FTC and FDA, meanwhile, have sent warning letters both to sellers of unapproved treatments and to multi-level marketing companies for unsubstantiated claims made by their independent distributors.

Tags: COVID-19, DOJ, FDA, FTC  |  Comments

Reese Witherspoon’s Clothing Company Receives Backlash for Changing Rules in Teacher Appreciation Dress Giveaway for Covid-19

Posted on April 30, 2020 by Andrew B. Lustigman, Morgan E. Spina

In 2017, California-based clothing company, Sunny Co. Clothing, posted a photo to its Instagram account displaying a model wearing Sunny Co. Clothing’s “Pamela” red, full-piece bathing suit. The caption stated that every person who reposts the image tagging Sunny Co. Clothing “will receive a FREE Pamela Sunny Suit.” Sunny Co. Clothing failed to set a maximum on the number of swimsuits available for the promotion. The post quickly went viral and Sunny Co. Clothing found itself in the undesirable position of not being able to fulfil its promotional obligations as it simply did not have enough swimsuits to meet the demand. Sunny Co. Clothing publicly learned the importance of having complete and conspicuously disclosed contest rules for social media giveaways. Reese Witherspoon’s fashion label, Draper James, is now learning the same lesson several years later. Read More ›

Tags: COVID-19, Sweepstakes Law, Sweeptstakes Contest  |  Comments

FDA and FTC Send Warning Letters to Companies Claiming That Products Can Help Boost Immune Systems Relating to Coronavirus Prevention

Posted on April 7, 2020 by Andrew B. Lustigman, Morgan E. Spina

The FDA and FTC have issued joint warning letters to companies selling products that they claim are able to treat or prevent coronavirus. The regulators sent the first set of such warning letters to several companies on March 6, 2020 and have continued to send such warning letters since. Read More ›

Tags: COVID-19, FDA, FTC  |  Comments
Back to Page